The management of anxiety in Alzheimer's disease - A pilot study of a single-blind randomised controlled trial using an intervention package with a three month follow-up
Not Applicable
Completed
- Conditions
- ervous System Diseases: Alzheimer's diseaseNervous System DiseasesAlzeihmer's disease
- Registration Number
- ISRCTN33534489
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants will be selected from 5 centres within North East London Mental Health Trust.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie anxiety management in Alzheimer's disease as explored in ISRCTN33534489?
How does the intervention package in ISRCTN33534489 compare to standard-of-care anxiolytics for Alzheimer's patients?
Are there specific biomarkers for Alzheimer's subtypes that predict response to non-pharmacological anxiety interventions?
What adverse events are associated with non-pharmacological anxiety therapies in Alzheimer's disease trials?
What combination approaches or competitor drugs target neuroinflammation in Alzheimer's anxiety management?